Bispectral Index Value Changes During Induction and Surgical Decompression in Head Injury Patients
NCT ID: NCT03480880
Last Updated: 2018-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2016-10-01
2017-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. This first part was designed to determine thiopentone dose requirement for induction of anaesthesia with and without the use of Bispectral Index monitoring - Participant and Care Provider in appropriate study arm blinded.
2. As a secondary outcome, Bispectral index monitoring was used to observe changes in neuronal function in intraoperative period as well as haemodynamic changes intraoperatively - Participant and Care Provider blinded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Empirical Mode Decomposition in the Electroencephalogram
NCT03303443
Outcomes of an Intraoperative Bispectral Index Monitor
NCT03052543
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)
NCT05337618
The Research Team Aims to Elucidate the Impact of ITBS (intermittent Theta Burst Stimulation) on the HPA Axis and Post-stroke Negative Emotions/depression by Conducting Human Experiments That Target Various Brain Regions.
NCT06899893
The Clinical Research of Needle Electrodes Used in Bispectral Index to Monitor the Depth of Anesthesia
NCT05130333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
2. Observation of Bispectral Index change in intraoperative period.
TREATMENT
DOUBLE
2. Anaesthetic care provider was blinded to Bispectral Index changes in second part of study.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group BIS
Thiopentone dosing during induction of anaesthesia based on guidance of Bispectral Index values.
Bispectral Index
Thiopentone was administered in 50 mg boluses during induction of anaesthesia, until reduction of Bispectral Index value to less than 50, and total dose of thiopentone recorded.
Group Clinical
Thiopentone dosing during induction of anaesthesia based on clinical guidance targeted to loss of eyelash reflex or loss of response to noxious stimulus.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bispectral Index
Thiopentone was administered in 50 mg boluses during induction of anaesthesia, until reduction of Bispectral Index value to less than 50, and total dose of thiopentone recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Extra Dural Hemorrhage
* Extracranial injuries
* Scalp lacerations
* History of Seizures
* No consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health and Neuro Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dhritiman Chakrabarti
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muthuchellappan Radhakrishnan, MD, DM
Role: STUDY_CHAIR
National Institute of Mental Health and Neuro Sciences, India
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIMHANS/DO/103rd IEC/2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.